LegoChem Biosciences, Inc. a biopharmaceutical company, focuses on the development of novel therapeutics utilizing its proprietary LegoChemistry medicinal drug discovery technology and antibody-drug conjugate platform (ADC). It engages in the research and development of ADC, anti-biotic, anti-coagulant, and anti-cancer therapeutics. The company offers its products in the forms of tablets and capsules. It has a research collaboration and license agreement with Iksuda Therapeutics for the development of antibody-drug conjugates in oncology. The company was founded in 2006 and is headquartered in Daejeon, South Korea.